1. Home
  2. PMAX vs SPRC Comparison

PMAX vs SPRC Comparison

Compare PMAX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Max Limited

PMAX

Powell Max Limited

SELL

Current Price

$2.65

Market Cap

4.5M

Sector

N/A

ML Signal

SELL

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$2.03

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMAX
SPRC
Founded
2019
2004
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.0M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
PMAX
SPRC
Price
$2.65
$2.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
3.4M
Earning Date
09-23-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,799,100.00
$1,306,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
187.98
52 Week Low
$1.56
$1.55
52 Week High
$25.12
$37.59

Technical Indicators

Market Signals
Indicator
PMAX
SPRC
Relative Strength Index (RSI) 59.40 39.57
Support Level $2.54 $1.55
Resistance Level $3.35 $2.26
Average True Range (ATR) 0.33 0.33
MACD 0.10 0.05
Stochastic Oscillator 67.60 25.99

Price Performance

Historical Comparison
PMAX
SPRC

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: